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Abstract
The evolutionarily conserved DNA topoisomerase II beta-binding protein 1 (TopBP1) functions in 
DNA replication, DNA damage response, and cell survival. We analyzed the role of TopBP1 in 
human and bovine papillomavirus genome replication. Consistent with prior reports, TopBP1 co-
localized in discrete nuclear foci and was in complex with papillomavirus E2 protein. Similar to 
E2, TopBP1 is recruited to the region of the viral origin of replication during G1/S and early S 
phase. TopBP1 knockdown increased, while over-expression decreased transient virus replication, 
without affecting cell cycle. Similarly, using cell lines harboring HPV-16 or HPV-31 genome, 
TopBP1 knockdown increased while over-expression reduced viral copy number relative to 
genomic DNA. We propose a model in which TopBP1 serves dual roles in viral replication: it is 
essential for initiation of replication yet it restricts viral copy number.
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Introduction
Papillomaviruses are approximately 8 kb double stranded DNA viruses that infect basal cells 
of stratified epithelia and productively amplify in differentiated suprabasal cells (Bedell et 
al., 1991; Howley, 1996). Human papillomavirus (HPV) genomes replicate as low copy 
number autonomous episomes. Similarly, bovine papillomavirus 1 (BPV-1) transforms 
murine cells and is maintained as a stable multicopy nuclear plasmid (Law et al., 1981). 
Virally encoded E1 and E2 proteins are essential for its replication during S phase (Chiang 
et al., 1992; Mohr et al., 1990; Ustav and Stenlund, 1991), which depends on multiple host 
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proteins such as DNA polymerase δ, Replication Protein A and Brd4 (Park et al., 1994; 
Wang et al., 2013). The E1 protein is a sequence specific DNA binding helicase (Hughes 
and Romanos, 1993; Yang et al., 1993). The E2 protein binds to specific DNA motifs in the 
viral regulatory region and is a transcriptional activator (Androphy et al., 1987; Phelps and 
Howley, 1987). E2 binds to E1; the transcriptional activity of E2 is not essential for viral 
replication (Grossel et al., 1996; Mohr et al., 1990). While metazoan origins typically span 
50–250 kb, viral origins are defined by short sequences of less than 100 bp. The E2–E1 
complex recognizes their respective adjacent motifs and this element acts as an origin of 
viral replication (ori). The subsequent ATP hydrolysis by E1 causes the E2 protein to 
dissociate and permits formation of hexameric E1 molecules on the ori (Abbate et al., 2004; 
Sanders and Stenlund, 1998).
Topoisomerase II- binding protein 1 (TopBP1), also known as Dpb11, Rad4, Cut5 (Yeast), 
Mus101 (Drosophila), is a functionally conserved protein with a BRCA1- C terminus 
(BRCT) domain [reviewed in (Garcia et al., 2005)]. Vertebrate TopBP1 participates in DNA 
replication and DNA damage repair processes (Balestrini et al., 2010; Kumagai et al., 2010; 
Makiniemi et al., 2001), is essential for cell survival (Yamane et al., 2002), and is required 
for embryonic development (Jeon et al., 2011). TopBP1 is also necessary for maintenance of 
genomic integrity (Kim et al., 2005) and has several roles in the G1/S transition such as 
loading of replication components and activation of CycE/Cdk2 (Jeon et al., 2007). Elevated 
expression of TopBP1 is believed to cause aggressive tumors by modulating the p53 
pathway (Liu et al., 2009). TopBP1 is capable of activating the DNA damage response 
pathway (DDR) protein ATR (Kumagai et al., 2006) and is known to interact with Claspin 
to promote Chk1 activity (Liu et al., 2006).
The HPV-16 E2 protein is known to associate with TopBP1 and this interaction increases 
the transcriptional and replication activity of E2 protein (Boner et al., f). TopBP1 is believed 
to act as a chromatin receptor of E2 protein especially in late stages of mitosis (Donaldson et 
al., 2007). An HPV-31 genome with an E2 mutation crippled for TopBP1 binding exhibited 
reduced replicative ability (Donaldson et al., 2012). In U2OS cells transfected with HPV18 
genome, TopBP1 co-localized with E1 containing foci suggesting association of TopBP1 
with viral replication centers (Reinson et al., 2013). These results imply co-operation 
between HPV proteins and TopBP1 in facilitating viral replication. Although the DDR is 
activated by HPV E1 and E7 proteins (Banerjee et al., 2011; Fradet-Turcotte A, 2011; 
Sakakibara et al., 2011), chemical inhibitors of the DDR pathway did not alter HPV 
replication (King et al., 2010; Reinson et al., 2013). In this context we explored the role of 
TopBP1 in HPV and BPV replication by modulating the levels of TopBP1 in different cell 
types.
Materials and Methods
Cell culture, Plasmids, Chemicals
C127, BPV-A3 murine C127 cells with BPV-1 episomes (Voitenleitner and Botchan, 2002), 
C33A, and J2 3T3 cells were maintained in DMEM with 10% FBS and 1× Pen/Strep. 
H1299 cells were maintained in RPMI media with 10% FBS having 1× Pen/Strep. HPV-BP 
cells (Sprague et al., 2002) that maintain 10–50 copies of HPV-16 episomes were cultured in 
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Keratinocyte Serum Free media (K-SFM) supplemented with bovine pituitary extract, EGF 
(Invitrogen) and 1× Pen/Strep. CIN612-9E cells (De Geest et al., 1993) that retain HPV-31 
episomes were grown in E-Media on J2 3T3 feeders pre-treated with 5 μg/ml mitomycin C 
as described (Bedell et al., 1991). Cells were transfected with Lipofectamine 2000 (C33A, 
H1299, BPV-A3) or with FugeneHD (HPV-BP, CIN612) at 1:1 and at 4:1 ratio to DNA, 
respectively. We obtained plasmids HPV-31 E1, E2, pFLORI31 and pCI-Rluc (Fradet-
Turcotte et al., 2010a), pSUPER-siScramble (knockdown control), pSUPER-siTopBP1 and 
full length human Flag-TopBP1 (Liu et al., 2004). The TopBP1 knockdown constructs used 
are human specific. pCG-BPV-E2 has been reported (Grossel et al., 1996). We used empty 
pcDNA3 as vector control. Mimosine and nocodazole were procured from Sigma, and 
thymidine was obtained from Alfa Aesar (Ward Hill, MA).
Antibodies
BPV anti-E2 (B201, II–I), anti-EE antibodies (Wang et al., 2009), and rabbit anti-TopBP1 
(Donaldson et al., 2007) have been reported. Commercial antibodies used were anti-Actin, 
(Sigma Aldrich) and mouse anti-TopBP1 (BD Transduction Laboratories, 611875).
Luciferase assay for viral replication
Luciferase based replication protocols essentially followed as described (Fradet-Turcotte et 
al., 2010b). Briefly, 80 ng each of HPV-31 E1, E2 and pFLORI31 constructs were co-
transfected along with 1 μg of TopBP1 shRNA (pSuper-siTopBP1) or over-expression 
(Flag-TopBP1) vectors or their respective controls (pSUPER-siSCramble, or pCDNA3) in 
12 well plate. For normalization, pCI-RLuc construct was included at 16 ng per well. Cells 
were lysed in Dual-Glo luciferase reagent (Promega) and both firefly and renilla luciferase 
activities were determined using PHERAStar FS (BMG Labtech). Luciferase activities were 
measured 48 h and 72 h after transfection. Relative replication was expressed by the ratio of 
firefly to renilla luciferase activity normalized to vector control.
Viral genome copy number determination by real time PCR
Cells were transfected with 2 μg of TopBP1 over-expression or knockdown constructs or 
their respective controls. 72 h post-transfection, HPV-BP or CIN612 cells were lysed in 10 
mM Tris – 1 mM EDTA (pH 8.0) with 0.1% SDS and 1× protease inhibitor cocktail, DNA 
was isolated using standard phenol:chloroform (PCA) method (Sambrook and Russell, 
2006). Real time PCR was performed with a BioRad CFX using Sso Fast Evagreen 
mastermix (BioRad) according to manufacturer’s protocol. The PCR primer sets were 
HPV-16 LCR: forward 5′ GGGTGTGTGCAAACCGTTTTGGGTTA 3′ and reverse 5′ 
CCGATTTCGGTTACGCCCTTAGTTT 3′; HPV-31 LCR: forward 5′ 
CCTGCTCCTCCCAATAGTCAT 3′ and reverse 5′ AAACGGACCGGGTGTACA 3′. 
DNA primer set #23 (Mendoza-Maldonado et al., 2010) was used for genomic DNA copy 
number determination. Results were analyzed using CFX manager software (BioRad).
Chromatin Immunoprecipitation (ChIP) assay
BPV-A3 or HPV-BP cells were synchronized as follows. For double thymidine block, cells 
were kept in 2.0 mM thymidine overnight, released in the morning and again blocked 
Kanginakudru et al. Page 3
Virology. Author manuscript; available in PMC 2016 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
overnight with 2.0 mM thymidine. For the mimosine block, cells were treated at 2 μM 
overnight. For G2 arrest, cells were treated at 100 nM of nocodazole overnight. After 
treatment, ChIP was performed as described in (Yu et al., 2007). Primer sets used for BPV-
LCR were forward 5′ GCCTTCTCAGCCAAAATGAA 3′ and reverse 5′ 
TGAGGTTTTGATCCGCCTAC 3′
Flow cytometry
Synchronized cells were fixed in 90% ethanol and stored in 4°C. The following day, cells 
were washed in PBS, treated with 50 μg/ml of RNase A- 50 μg/ml Propidium iodide for 20 
min, run on FACS Caliber and analyzed with FlowJo software. To test the effect of TopBP1 
protein levels on cell cycle, C33A or H1299 cells were transfected with either over-
expression or knockdown plasmids. After 48 h, cells were harvested and processed for flow 
cytometry.
Western blot of TopBP1
H1299 or C33A cells were transfected with pSUPER-siTopBP1 or pSUPER-siScramble at 3 
μg per well of a six well plate. After 48 h, cells were lysed in urea buffer (6 M urea, 100 mM 
NaH2PO4, and 20 mM Tris pH-6.8). 20 μg of total protein were run on a 4–15% gradient gel 
(BioRad) and transferred onto PVDF membranes. Rabbit anti-TopBP1 (R1180) antibody 
was used at 1:2000, and anti-Actin antibody at 1:1000 dilutions. For over-expression studies, 
H1299 cells were transfected with vector control or Flag-TopBP1 plasmids at 3 μg per well 
of a six well plate.
In situ proximity ligation assay (PLA)
In situ PLA was performed using the PLA Red kit (Olink Biosciences). BPV-A3 cells were 
first blocked in S phase by double thymidine treatment, fixed in 4% para-formaldehyde for 
10 min, permeabilized for 15 min in 0.5% Triton-X 100/PBS, washed in PBS, blocked with 
5% goat serum in 0.2% Triton- X 100/PBS, then incubated overnight with primary antibody 
combinations (E2-TopBP1 or E1-E2) at 4°C . The PLA then followed the manufacturer’s 
protocol. Briefly, cover slips were washed in buffer A, incubated with PLA probe PLUS and 
MINUS for one hour at 37°C, washed twice and the probes were ligated for 30 min. 
Amplification was performed for 100 min at 37°C, washed twice in buffer A and B. Cover 
slips were mounted in Duolink in situ mounting media. Cells were analyzed with a Nikon 
microscope. In case of C127 cells, eGFP was co-transfected with or without pCG-E2. PLA 
signals were counted only from green fluorescent cells. Two independent transfections were 
carried out, the counts were averaged and calculated as percentage of transfected cells 
displaying PLA foci.
Statistical analysis
Unless specifically mentioned, all experiments were repeated thrice and results were 
averaged. Error bars denote the standard deviation. Statistical significance was determined 
using Student’s t-test.
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Results
TopBP1 co-localizes with BPV E2 in nuclear foci
As it was previously reported that TopBP1 co-immunoprecipitates with E2, we sought to 
further characterize this interaction in vivo. To confirm the protein-protein interaction 
between TopBP1 and E2, in situ proximity ligation assays (PLA) were performed 
(Leuchowius et al., 2011). PLA is a modified immunofluorescence assay in which secondary 
antibody is conjugated to specific DNA sequences. When two secondary antibodies are in 
close proximity (~ 40 nm), DNA can be ligated, amplified and detected by hybridization 
with specific fluorescent probes. In BPV-A3 cells, we detected the in vivo interaction 
between the E2 protein and endogenous TopBP1 as demonstrated by formation of 
fluorescent spots inside the nucleus. We also observed similar interaction between E1 and 
E2 (Figure 1A). These cells harbor hundreds of copies of BPV genome due to high levels of 
an E2 protein with three serine to alanine mutations (McBride and Howley, 1991). We also 
repeated the assay in C127 cells transfected with (or without) BPV-E2. C127 cells 
transfected with BPV-E2 became positive in PLA reactions with TopBP1 (Figure 1B). 
Transfection efficiency was normalized to GFP expression and PLA signals were counted in 
transfected cells. As shown in the graph, not all C127 cells showed the PLA signal, possibly 
because of low level or a transient interaction between E2-TopBP1. More than 30% of the 
cells with PLA signal had more than one such fluorescent puncta.
TopBP1 is localized near the BPV and HPV ori in G1/S and early S phase
We next investigated whether TopBP1 is recruited to the viral genome. BPV-A3 cells 
harboring replicating BPV genomes were synchronized in different stages of cell cycle using 
mimosine, double thymidine or nocodazole. Cell cycle profiles were analyzed by flow 
cytometry. As shown in the inset of Figure 2A, cells accumulated in G1/S, early S and G2 
after mimosine, double thymidine and nocodazole treatment respectively. Since 
papillomavirus oncoproteins are known to abrogate cell-cycle checkpoints (Heilman et al., 
2009; Liu et al., 2007), we observed that BPV-A3 cells were not completely arrested and a 
small portion of cells progressed through cell cycle. ChIP was performed using BPV E2, 
TopBP1 or control EE antibodies. As expected (Melanson and Androphy, 2009), BPV E2 
was present at the LCR region at very high levels in mimosine and double thymidine 
synchronized cells. Compared to the EE antibody control, TopBP1 ChIP was increased by 
40 fold in mimosine treated G1/S cells and by 12 fold in double thymidine treated early S 
phase cells. Levels slightly above background (EE antibody) were detected in nocodazole 
treated mitotic arrested cells (Figure 2A). These results confirm enrichment of TopBP1 near 
the viral origin in G1/S or early S phases. TopBP1 is similarly localized to the LCR region 
in HPV-BP cells harboring episomal HPV-16 genome (Figure 2B) in a cell cycle dependent 
manner. The fold change in HPV-BP was not as high as that of BPV, likely due to antibody 
affinity and/or copy number difference. Our results also reaffirm that the virus replication is 
in synchrony with cell cycle and initiated in S phase during episomal maintenance. We 
could not detect the endogenous HPV-16 E2 protein in HPV-BP cells due to lack of a 
specific antibody.
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Over-expression of TopBP1 inhibits while its depletion promotes viral replication
We sought to understand the role TopBP1 might play in viral replication. We used two 
human cell lines to examine the effect of TopBP1 in transient replication assays: H1299, a 
non-small cell lung carcinoma cell line that has been successfully used for stable knockdown 
of TopBP1 (Liu et al., 2011) as well as for understanding HPV E6 and E7 functions 
(Mesplede et al., 2012; Todorovic et al., 2012) and C33A, a cervical carcinoma cell line 
often used in HPV replication assays. HPV-31 E1, E2 and the pFLORI31 reporter plasmids 
were co-transfected with either TopBP1 over-expression or knockdown constructs. There 
was significant reduction in protein level with the pSUPER-siTopBP1 construct compared to 
pSUPER-siScramble while over expression resulted in two to three fold increased TopBP1 
(Figure 3A). At 48 h, knockdown of TopBP1 in both H1299 and C33A increased viral 
replication by 48% and 26% respectively. In contrast, its over-expression resulted in a nearly 
two fold decrease in HPV-31 replication in H1299 and 21% reduction in C33A cells. At 72 
h post transfection, the effects were more pronounced with knockdown causing 60% and 
40% increase in H1299 and C33A respectively, while over-expression decreased the viral 
replication by 60% and 46% in H1299 and C33A respectively (Figure 3B). As shown in 
Figures 4 A and B, modulation of TopBP1 protein levels did not significantly affect cell 
cycle compared to respective controls. We did observe that the pSUPER vector backbone 
slightly altered the “S” phase (as shown by pSUPER-siSCramble) in C33A cells, but the cell 
cycle patterns were similar for both pSUPER-siTopBP1 and pSUPERsi-Scrambled samples. 
Using trypan blue staining, we did not detect any significant cell death associated with 
TopBP1 manipulations in C33A or H1299, as treatments showed similar (94 ± 4 %) cell 
survival.
Although we normalized the firefly luciferase (replication related) activity to renilla 
luciferase (transcription related) activity, we wished to confirm that the observed result was 
a result of genome replication. We repeated this assay by excluding HPV-31-E1 or E2 in 
this assay. As shown in Figure 5, the absence of E1 or E2 resulted in nearly 20 fold decrease 
in luciferase activity. In the absence of viral proteins, there was no significant difference in 
luciferase activity, suggesting an influential role of TopBP1 on E1-E2 dependent replication.
To demonstrate the consequences of TopBP1 manipulation on a stable HPV replicon, HPV-
BP cells were transfected with either over-expression or shRNA constructs of TopBP1. 
After 48 or 72 h post transfection, total DNA was isolated and viral copy number was 
determined by real time PCR using primers specific for the HPV-16 LCR region. A genomic 
DNA amplicon was included for normalization. Viral copy number increased to 150% at 48 
h post-transfection and nearly threefold in TopBP1 knockdown cells at 72 h (Figure 6A and 
B). On the other-hand, over-expression of TopBP1 resulted in 20% and 50% reduction in 
copy number at 48 and 72 h respectively. We also tested whether analogous observations 
would hold in CIN612 cells. As shown in Figure 6B, heterologous expression of TopBP1 
significantly decreased viral copy number relative to genomic DNA while knockdown 
increased viral content. Therefore, TopBP1 not only effects viral replication in transient 
assays, but also reduces viral copy number in cells maintaining HPV episomes.
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Discussion
Papillomavirus genomes are maintained as low copy number episomes in basal epithelial 
cells and are amplified to thousands of copies in nuclei of upper level differentiating cells. 
While activation of the DDR pathway is known to stimulate the amplification stage, a role 
for DDR factors in the genome maintenance phase has not been observed. In the present 
study, we investigated the role of TopBP1 protein in HPV and BPV replication. TopBP1 
plays an essential role during genomic DNA replication by facilitating loading of CDC45 at 
the origin (Kumagai et al., 2010). After replication initiates, TopBP1 is no longer necessary 
for continued DNA synthesis (Makiniemi et al., 2001). We demonstrate that the TopBP1 
protein is present at the HPV and BPV origins of replication in G1/S phases of cell cycle 
(Figs. 2 A, B). This is presumably facilitated by its binding to the HPV E2 protein in vivo as 
shown here by in-situ PLA. We also observed interaction between BPV E1 and E2 by PLA 
in a murine cell line that stably maintains viral episomes (Figure 1A). In addition to strong 
signals, E1–E2 PLA showed a few faint signals, which were not observed in E2-TopBP1 
interactions, possibly because of different affinities of proteins to each other and/or to the 
specific antibodies. The cell cycle specific localization of TopBP1 to the viral origin in G1/S 
implicates its role in the initiation of viral DNA replication. This is supported by a previous 
study wherein an HPV-16 genome encoding an E2 mutant crippled for TopBP1 failed to be 
maintained episomally in cultured keratinocytes (Donaldson et al., 2012). As the cells 
progressed through mitosis, the presence of TopBP1 near the viral ori decreased, indicating 
its displacement at this stage (Figure 2 A, B). It has been reported that the E2 binding 
protein Brd4 is also necessary for initiation of HPV replication and subsequently displaced 
from viral DNA foci (Sakakibara et al., 2013; Wang et al., 2013). Our results suggest a 
similar role for TopBP1.
Progression of a replication fork may stall upon collision with other DNA bound complexes, 
or when the template is damaged as occurs with nucleotide depletion or from chemical 
agents. Induction of DNA damage following HPV-18 E1 over-expression has been shown 
by comet assay (Reinson et al., 2013). This implies that E1 or an associated factor is capable 
of inducing genomic damage and the DDR. TopBP1 is recruited to the replisome by DDR 
mediators of the Mre11-Nbs1-Rad50 complex (Duursma et al., 2013; Makiniemi et al., 
2001). Phosphorylated TopBP1 is necessary for a cascade of downstream protein 
phosphorylations that result in activation of Chk1, which restricts further origin firing 
(Feijoo et al., 2001). We observed that partial knockdown of TopBP1 consistently increased 
transient viral replication and viral episomes (Figures 3 and 6). The opposite outcome was 
observed following over-expression of TopBP1, which resulted in reduced viral replication 
in luciferase based reporter assays. We confirmed that the change in replication is a 
consequence of TopBP1 level on replication unrelated to cell cycle (Figure 4 A and B). 
Moreover, heterologous expression of TopBP1 consistently decreased viral copy number in 
keratinocytes stably carrying episomal HPV-16 or HPV-31 genomes (Figure 6). In the 
absence of E1 or E2, replication was not observed irrespective of TopBP1 protein level 
(Figure 5). We conclude that the sustained presence of TopBP1 hindered virus replication.
Targeting the TopBP1 pathway is not unprecedented in viral replication. Certain adenovirus 
serotypes inhibit ATR activation by targeting the TopBP1 protein for degradation, inferring 
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that the DDR restricts adenoviral replication (Blackford et al., 2010). Another indirect link 
between TopBP1 and HPV replication may lie in the Fanconi Anemia (FA) pathway. FA is 
associated with increased susceptibility to HPV induced carcinogenesis (Kutler et al., 2003; 
Park et al., 2010). The viral E7 oncoprotein was reported to activate the FA pathway and 
accelerated chromosomal instability has been attributed to a defective FA pathway (Spardy 
et al., 2007). The FA pathway is believed to restrict the HPV life cycle as loss of FANCD2 
component accelerates HPV amplification (Hoskins et al., 2012). Defective FANCM is also 
known to displace TopBP1 from chromatin (Schwab et al., 2010). Whether there is any link 
between HPV amplification and failure to retain TopBP1 on chromatin in FA is not very 
clear, but our results do indicate that after replication is initiated, removal of TopBP1 would 
facilitate HPV replication during episomal maintenance.
The experiments presented here suggest differential roles of TopBP1 in PV replication. 
Chromatin immunoprecipitation (ChIP) results support the essential role of TopBP1 for 
replication initiation, while over-expression of TopBP1 exerts a negative regulatory role. We 
believe that, as a key regulator of the DDR pathway, TopBP1 plays a critical role in fork 
stability during episomal replication. Since PV replication is presumed to occur by 
bidirectional DNA synthesis, the replication fork will converge on each episome. This poses 
the problem of colliding replisomes that require resolution. The DDR may be critical to 
appropriately resolve this possible fork collapse. A collapsed fork is likely to affect 
episomes more severely than the genomic DNA since the latter have multiple origins and 
thus could restart more efficiently. Alternatively, manipulation of the DDR by modulating 
the levels of TopBP1 may cause a replication block from which the episomal DNA cannot 
be rescued. A previous study using chemicals to alter HPV DNA structure showed that 
mounting of a DDR eliminated HPV episomes, possibly by activating Rad9-Hus1-Rad1 (9–
1–1) (Edwards et al., 2013). It was suggested that the 9–1–1 complex may recruit enzymatic 
complexes that destroyed the HPV genomes. Our study also suggests that unscheduled or 
uncontrolled activation of TopBP1 is not conducive for PV replication, reconfirming the fine 
balance of host proteins for successful replication and episome maintenance. We also cannot 
rule out the possibility of TopBP1 playing a role during DNA segregation that affects 
episomal copy number. In differentiating cells where HPV undergoes rapid amplification, 
the DDR is a critical factor for promoting virus replication and the potential role of TopBP1 
might be altogether different. Further studies are necessary to uncover the exact mechanism 
by which TopBP1 leads to episomal loss and/or replication block during HPV maintenance 
and how and when exactly TopBP1 is displaced during replication.
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Research highlight
• Protein interaction study confirmed In situ interaction between TopBP1 and E2
• TopBP1 present at papillomavirus ori in G1/S and early S phase of cell cycle
• TopBP1 knockdown increased, over-expression reduced virus replication
• TopBP1 protein level change did not influence cell survival or cell cycle
• ToPBP1 displaced from papillomavirus ori after initiation of replication
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Figure 1. 
In vivo co-localization of BPV-E2 with TopBP1. (A) In situ proximity ligation assay (PLA) 
between E1 – E2 (left) and TopBP1 – E2 (right) in BPV-A3 cells synchronized by double-
thymidine block. Fluorescent spots indicate interaction based PCR amplification occurring 
in the nucleus (stained blue). (B) PLA of transfected BPV E2 and endogenous TopBP1 in 
C127 cells synchronized by double thymidine. Fluorescent spot indicates interaction based 
PCR amplification. Graph shows the percentage distribution of PLA signals in GFP 
expressing transfected C127 cells.
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Figure 2. 
Both E2 and TopBP1 ChIP to the LCR region at G1/S and early S stages. (A) BPV-A3 cells 
were treated with mimosine, thymidine or nocodazole to arrest in different cell cycle stages. 
Inset diagram shows flow cytometry based cell cycle analysis. Bar indicates standard 
deviation, * p < 0.05 between TopBP1 antibody and control antibody. (B) TopBP1 is 
localized to HPV-16 LCR of HPV-BP cell line. Bar indicates standard deviation, * p < 0.05 
between TopBP1 antibody and control antibody.
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Figure 3. 
Transient HPV-31 replication was altered by modulating TopBP1 levels. (A) Western blot 
of TopBP1 in H1299 and C33A cells. Left panels show the western blot from H1299 and 
C33A cells transfected with pSUPER-siTopBP1 or its vector control. Right panel shows the 
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western blot from H1299 cells transfected with vector or Flag-TopBP1 constructs. Actin was 
used as a loading control. Legend – V – vector controls, sh – pSUPER-siTopBP1, FT – 
Flag-TopBP1. (B) HPV-31 luciferase based assays in H1299 (upper) and C33A (lower) cells 
having either Knockdown or over-expression constructs of TopBP1. p < 0.05 between 
control and over-expression/knockdown at both time points for H1299, while it was 
significant at 72 hours for C33A.
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Figure 4. 
TopBP1 level does not alter cell cycle. C33A (A) and H1299 (B) cells were transfected with 
either over-expression or knockdown constructs (or respective controls). Flow analysis was 
carried out 48 h post-transfection.
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Figure 5. 
TopBP1 effect on HPV-31 replication depends on both E1 and E2. HPV-31 luciferase based 
assays in C33A cells with or without HPV-31 E1/E2 in TopBP1 knockdown or over-
expressing cells. * p < 0.05.
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Figure 6. 
Episomal HPV replication is altered by changing TopBP1 levels. (A) Quantitative PCR of 
HPV-16 LCR in TopBP1 protein knockdown or over-expressing HPV-BP cells. HPV-16 
LCR DNA values were normalized to PCR of genomic locus 23. * p < 0.05. (B) 
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Quantitative PCR of HPV-31 LCR in TopBP1 protein knockdown or over-expressing 
CIN612 cells. HPV-31 LCR values were normalized to PCR of genomic locus 23. * p < 
0.05.
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